FRESENIUS MEDICAL CARE AG Other Expense By Function
FRESENIUS MEDICAL CARE AG (FMCQF) reported Other Expense By Function of EUR 720.66 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OtherExpenseByFunction · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG other expense by function for the quarter ending 2025-12-31 was 143.81M EUR, a 62.32% decline year-over-year.
- FRESENIUS MEDICAL CARE AG other expense by function for the quarter ending 2025-09-30 was 125.27M EUR, a 4.82% increase year-over-year.
- FRESENIUS MEDICAL CARE AG other expense by function for the quarter ending 2025-06-30 was 347.10M EUR, a 87.40% increase year-over-year.
- FRESENIUS MEDICAL CARE AG other expense by function for the quarter ending 2025-03-31 was 247.57M EUR, a 0.42% increase year-over-year.
| Period end | Other Expense By Function 3 month | Other Expense By Function 6 month | Other Expense By Function 9 month | Other Expense By Function 12 month |
|---|---|---|---|---|
| 2025-12-31 | 143.81M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 269.09M EUR derived: sum of 2 quarters · filed 2026-02-24 | 616.19M EUR derived: sum of 3 quarters · filed 2026-02-24 | 720.66M EUR 20-F · filed 2026-02-24 |
| 2025-09-30 | 125.27M EUR 6-K · filed 2025-11-04 | 472.38M EUR derived: sum of 2 quarters · filed 2025-11-04 | 576.84M EUR 6-K · filed 2025-11-04 | 1.10B EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2025-06-30 | 347.10M EUR 6-K · filed 2025-08-05 | 594.67M EUR 6-K · filed 2025-08-05 | 976.35M EUR derived: sum of 3 quarters · filed 2026-02-24 | 1.10B EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2025-03-31 | 247.57M EUR 6-K · filed 2025-05-06 | 629.25M EUR derived: sum of 2 quarters · filed 2026-02-24 | 748.75M EUR derived: sum of 3 quarters · filed 2026-02-24 | 933.97M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-12-31 | 381.68M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 501.19M EUR derived: sum of 2 quarters · filed 2026-02-24 | 686.40M EUR derived: sum of 3 quarters · filed 2026-02-24 | 932.94M EUR 20-F · filed 2026-02-24 |
| 2024-09-30 | 119.51M EUR 6-K · filed 2025-11-04 | 304.73M EUR derived: sum of 2 quarters · filed 2025-11-04 | 551.26M EUR 6-K · filed 2025-11-04 | 842.83M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | 185.22M EUR 6-K · filed 2025-08-05 | 431.75M EUR 6-K · filed 2025-08-05 | 723.32M EUR derived: sum of 3 quarters · filed 2026-02-24 | 868.50M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | 246.53M EUR 6-K · filed 2025-05-06 | 538.10M EUR derived: sum of 2 quarters · filed 2026-02-24 | 683.29M EUR derived: sum of 3 quarters · filed 2026-02-24 | 815.55M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | 291.57M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 436.75M EUR derived: sum of 2 quarters · filed 2026-02-24 | 569.02M EUR derived: sum of 3 quarters · filed 2026-02-24 | 764.29M EUR 20-F · filed 2026-02-24 |
| 2023-09-30 | 145.19M EUR 6-K · filed 2024-11-05 | 277.45M EUR derived: sum of 2 quarters · filed 2024-11-05 | 472.73M EUR 6-K · filed 2024-11-05 | 657.59M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | 132.26M EUR 6-K · filed 2024-07-30 | 327.54M EUR 6-K · filed 2024-07-30 | 512.41M EUR derived: sum of 3 quarters · filed 2025-02-25 | 727.77M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | 195.28M EUR 6-K · filed 2024-05-07 | 380.14M EUR derived: sum of 2 quarters · filed 2025-02-25 | 595.50M EUR derived: sum of 3 quarters · filed 2025-02-25 | 816.95M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | 184.87M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-25 | 400.23M EUR derived: sum of 2 quarters · filed 2025-02-25 | 621.67M EUR derived: sum of 3 quarters · filed 2025-02-25 | 747.55M EUR 20-F · filed 2025-02-25 |
| 2022-09-30 | 215.36M EUR 6-K · filed 2023-11-02 | 436.81M EUR derived: sum of 2 quarters · filed 2023-11-02 | 562.69M EUR 6-K · filed 2023-11-02 | |
| 2022-06-30 | 221.44M EUR 6-K · filed 2023-08-02 | 347.33M EUR 6-K · filed 2023-08-02 | ||
| 2022-03-31 | 125.88M EUR 6-K · filed 2023-05-09 | |||
| 2021-12-31 | 587.09M EUR 20-F · filed 2024-02-20 |